Delivery Order SPE2DB24D1107-SPE2DB25FZEK1

Award Date 2/12/25
Potential Completion Date 2/13/25
Potential Value $16K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $3,623.88, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of WEGOVY 0.25 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, with an ultimate completion date of August 27, 2024. This contract is a Delivery Order, with a Firm Fixed Price pricing type. The contract was not set aside for any specific business classification....
This federal contract award, valued at $3,710.36, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for WEGOVY 0.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, with a completion date of December 30, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award, valued at $11,528.17, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of WEGOVY 0.25 MG/0.5 ML PEN 0.5ML, a specialty medication, with a completion date of November 15, 2024. This is a firm fixed-price delivery order contract, indicating a pre-determined pricing structure. The award is not designated as a set-aside contract,...
This federal contract award, valued at $1,228.50, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of WEGOVY 1 MG/0.5 ML PEN 0.5ML. The contract is a Delivery Order with a Firm Fixed Price pricing type and an ultimate completion date of January 21, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award, valued at $8,571.17, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of WEGOVY 0.25 MG/0.5 ML PEN 0.5ML, a specialty medication, with a completion date of November 14, 2024. This appears to be a delivery order, with a firm fixed price pricing type. The contract is not designated with a set-aside requirement, indicating open...
This federal contract award, valued at $17,840.03, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of WEGOVY 2.4 MG/0.75 ML PEN 0.75ML, a pharmaceutical product, with a completion date of December 13, 2023. The contract type is a Delivery Order with a Firm Fixed Price pricing mechanism, and there was no set-aside designation....
This federal contract award, valued at $6,837.16, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of WEGOVY 1 MG/0.5 ML PEN 0.5ML, a medical product, with a completion date of February 7, 2024. The contract is a Delivery Order placed under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, valued at $999,999,999 and running through...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,187.46 Firm Fixed Price Delivery Order is for the supply of WEGOVY 0.25 MG/0.5 ML PEN 0.5ML, a specialty medication. The contract has an ultimate completion date of October 21, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $23,555.10, is a Delivery Order for the supply of WEGOVY 0.25 MG/0.5 ML PEN 0.5ML, a prescription medication. The contract has an ultimate completion date of January 8, 2025 and is a Firm Fixed Price arrangement. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,576.83, is for the delivery of WEGOVY 1.7 MG/0.75 ML PEN 0.75ML, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is February 13, 2025. The contract does not have a set-aside designation, indicating open...
  • SPE2DB24D1107
    Indefinite Delivery Contract
  • SPE2DB24D1107-SPE2DB25FZEK1
    Delivery Order

This federal contract award, valued at $16,112.79, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract provides for the delivery of WEGOVY 0.25 MG/0.5 ML PEN 0.5ML, a medical product, with a completion date of February 13, 2025. This contract is a delivery order type, with a firm fixed price pricing structure. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 5/14/25, 10:23 AM